European watchdog partially approves new Alzheimer’s drug

Europe’s medicines watchdog on Thursday partially approved a marketing request for a long-awaited new treatment for Alzheimer’s disease, reversing an earlier decision not to give it the green light.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup